Farmington, Connecticut – Mott Corporation, a high precision filtration company trusted by the world’s best technical and performance brands since 1959, celebrates the grand opening of their new rapid prototype manufacturing cell. This new manufacturing cell enables quick prototype development of next generation technology for many Fortune 500 companies on the cutting edge of science and technology.
Utilizing this rapid prototype cell, Mott developed next generation technology for chromatography labs by incorporating 3D printing. Mott’s new patent-pending technology will be used in labs across the globe to improve accuracy of test results and analysis in critical fields such as cancer research and water pollution.
Mott manufactures products for wide range of industries and applications, including the next generation of smartphone manufacturing, new methods for safely processing chemicals, improving beer and wine fermentation, and filtering bacteria from the NASA Mars rover. The prototype cell is expected to increase the speed to innovation for these industries.
As an employee owned company, meaning that every employee from the shop-floor to the CEO owns shares in the company, the development of this rapid prototype cell represents a bright future for Mott employees and business in Connecticut.
Source: Mott Corp.
Latest from Today's Medical Developments
- IMTS 2026 runs Sept. 14-19 at McCormick Place in Chicago, Illinois
- Master Bond’s MasterSil 800Med
- ZEISS celebrates 100 years of advancing innovation in the US
- Teleflex sells acute care and urology businesses for $2.03 billion
- HANNOVER MESSE: Where research and manufacturing meet
- What’s next for the design and manufacturing industry in 2026?
- Arcline to sell Medical Manufacturing Technologies to Perimeter Solutions
- Decline in German machine tool orders bottoming out